Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gascon

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Neuropeptides|July 31, 2002
Differences in the expression of neurokinin receptor in neural and bone marrow mesenchymal cells: implications for neuronal expansion from bone marrow cellsP S Bandari, J Qian, G Yehia, et al.
Ocular Immunology and Inflammation|April 11, 2024
Epidemiological, Clinical, and Therapeutic Profile of Uveitis in Multiple Sclerosis: A Multicenter StudyR Fitoussi, P Gascon, D Denis, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 6, 2016
Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanomaF Aya, A Fernandez-Martinez, L Gaba, et al.
Blood|August 1, 1992
Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboonsF Herodin, J C Mestries, D Janodet, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1992
Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in miceM P Gascon, H C Porchet, J Y Le Cotonnec, et al.
British Journal of Cancer|May 6, 2008
Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation studyA Awada, J Albanell, P A Canney, et al.
New Jersey Medicine : the Journal of the Medical Society of New Jersey|November 1, 1990
Monoclonal antibody therapy of cancerD M Goldenberg, R M Sharkey, H Goldenberg, et al.
Blood|May 9, 2001
Mimicry between neurokinin-1 and fibronectin may explain the transport and stability of increased substance P immunoreactivity in patients with bone marrow fibrosisP Rameshwar, D D Joshi, P Yadav, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Incidental versus symptomatic venous thrombosis in cancer: a prospective observational study of 340 consecutive patientsC Font, B Farrús, L Vidal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2007
Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxelJ Domingo-Domenech, P L Fernandez, X Filella, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Neuropeptides|July 31, 2002
Differences in the expression of neurokinin receptor in neural and bone marrow mesenchymal cells: implications for neuronal expansion from bone marrow cellsP S Bandari, J Qian, G Yehia, et al.
Ocular Immunology and Inflammation|April 11, 2024
Epidemiological, Clinical, and Therapeutic Profile of Uveitis in Multiple Sclerosis: A Multicenter StudyR Fitoussi, P Gascon, D Denis, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 6, 2016
Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanomaF Aya, A Fernandez-Martinez, L Gaba, et al.
Blood|August 1, 1992
Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboonsF Herodin, J C Mestries, D Janodet, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1992
Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in miceM P Gascon, H C Porchet, J Y Le Cotonnec, et al.
British Journal of Cancer|May 6, 2008
Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation studyA Awada, J Albanell, P A Canney, et al.
New Jersey Medicine : the Journal of the Medical Society of New Jersey|November 1, 1990
Monoclonal antibody therapy of cancerD M Goldenberg, R M Sharkey, H Goldenberg, et al.
Blood|May 9, 2001
Mimicry between neurokinin-1 and fibronectin may explain the transport and stability of increased substance P immunoreactivity in patients with bone marrow fibrosisP Rameshwar, D D Joshi, P Yadav, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Incidental versus symptomatic venous thrombosis in cancer: a prospective observational study of 340 consecutive patientsC Font, B Farrús, L Vidal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2007
Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxelJ Domingo-Domenech, P L Fernandez, X Filella, et al.
Pageof 10